Search

  • Sort by

  • Category

  • Post Type

  • Reset

Interchange 2011 Wrap Up

October 28, 2011
Posted in ,

From the Maryland Attorney General, to the International Association of Patient Organizations, the second annual Partnership for Safe Medicines Interchange 2011 provided local and international perspectives on the issues involving counterfeit medicine. The Partnership for Safe Medicines 2011 Interchange on October 27, began with dynamic remarks from Colorado Senator Michael Bennet and Congressman Jim Matheson of Utah highlighting the risks…

Read More

Keynote Address; Deputy Director Kumar Kibble

October 27, 2011
Posted in ,

Deputy Director Kumar Kibble of the U.s. Immigration and Customs Enforcement (ICE), Department of Homeland Security delivered the keynote address.   Kibble started his remarks by reminding us that he is personally inspired Dr. Francses Kelsey of the FDA who blocked the use of thalidomide in the US for pregnant women in 1960, while over 10,000 children in other countries suffered serious birth defects…

Read More

Under Secretary of State Hormats at Interchange: Global Collaboration Key to Curb the Spread of Counterfeit Medicines

October 27, 2011
Posted in ,

Collaboration within the U.S. government, collaboration between governments themselves, and collaboration with the private sector and, all stakeholder groups is essential to the fight against counterfeit and substandard medicines, said U.S. Under Secretary of State Robert D. Hormats during a speech today at the annual Interchange hosted today by the Partnership for Safe Medicines (PSM).

Read More

Kumar Kibble

October 27, 2011
Posted in
Read More

Jeremiah Mwangi

October 27, 2011
Posted in
Read More

Panel 3: Jeremiah Mwangi, International Alliance of Patients’ Organizations

October 27, 2011
Posted in ,

At the third panel, "Safe Medicines: The Role of Patients & Healthcare Professionals," Jeremiah Mwangi, Policy & External Affairs Director, International Alliance of Patients' Organizations, spoke on the role of patients.   Mwangi said that counterfeit drugs are a matter of patient safety, eroding trust in healthcare systems, and creating a public health risk. IAPO has called for a global approach…

Read More

Panel 3: Connie Jung, Office of Drug Security, Integrity and Recalls

October 27, 2011
Posted in ,

The second panelist, Connie Jung from the Office of Drug Security, Integrity and Recall from the U.S. Food and Drug Administration spoke about how to help patients protect themselves from counterfeit drugs. She said that patients first of all need to be aware of the risk of receiving counterfeit medications and potential problems associated with them.  FDA is committed to…

Read More

Panel 3: Xuanhao Chan, International Pharmaceutical Federation

October 27, 2011
Posted in ,

Bejon Misra, Founder of Partnership for Safe Medicines India, moderated the third panel, "The Role of Patients & Healthcare Professionals."   Misra began the session by showing a video that highlights the work of PSM India.  Misra began by distributing tokens of appreciation from the Board of PSM India to the Board of Partnership for Safe Medicines, saying that PSM…

Read More

Under Secretary Robert Hormats talks about international outreach to fight fake drugs

October 27, 2011
Posted in

Bob Hormats, Under Secretary of State for Economic, Energy and Agricultural Affairs was the luncheon speaker at the Partnership for Safe Medicines 2011 Interchange. Below is a transcript of Under Secretary Hormats remarks. I’m delighted that you asked me to speak today.  The work that the Partnership for Safe Medicines is important. Making sure that our citizens take safe medicines…

Read More

Panel 2: Maryland Attorney General, Douglas F. Gansler

October 27, 2011
Posted in ,

Maryland Attorney General, Douglas F. Gansler, spoke on Panel 2.   Said Gansler, "We all have a blind trust in the drugs we take, the doctor says we'll get better when we take it, and we trust that medication is what it purports to be. "But counterfeit drugs make it not the case. " Said Gansler, with counterfeit drugs being…

Read More